{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:13:44Z","timestamp":1778663624861,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40123-023-00739-4","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T10:01:58Z","timestamp":1686218518000},"page":"2199-2208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy"],"prefix":"10.1007","volume":"12","author":[{"given":"Andrea","family":"Servillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Zucchiatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Grachova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Prascina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Tombolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Dorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Mainster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"739_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen S, Balaratnasingam C, Kaden TR, et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology. 2019;126(4):576\u201388.","journal-title":"Ophthalmology"},{"issue":"2","key":"739_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126\u201345.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"739_CR4","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/eye.2010.130","volume":"24","author":"M Gemenetzi","year":"2010","unstructured":"Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010;24(12):1743\u201356.","journal-title":"Eye (Lond)"},{"issue":"5","key":"739_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/IAE.0000000000003004","volume":"41","author":"RF Spaide","year":"2021","unstructured":"Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous anastomosis in pachychoroid-related disorders. Retina. 2021;41(5):997\u20131004.","journal-title":"Retina"},{"key":"739_CR6","doi-asserted-by":"crossref","unstructured":"Iacono P, Da Pozzo S, Varano M, Parravano M. Photodynamic therapy with verteporfin for chronic central serous chorioretinopathy: a review of data and efficacy. Pharmaceuticals (Basel). 2020;13(11):349.","DOI":"10.3390\/ph13110349"},{"key":"739_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2020.04.007","volume":"216","author":"TJ van Rijssen","year":"2020","unstructured":"van Rijssen TJ, van Dijk EHC, Scholz P, et al. Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE trial. Am J Ophthalmol. 2020;216:80\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"739_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/08820539909069538","volume":"14","author":"MA Mainster","year":"1999","unstructured":"Mainster MA. Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol. 1999;14(4):200\u20139.","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"739_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00417-005-0175-4","volume":"244","author":"N Hussain","year":"2006","unstructured":"Hussain N, Khanna R, Hussain A, Das T. Transpupillary thermotherapy for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):1045\u201351.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"739_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/OPTH.S16014","volume":"5","author":"GL Giudice","year":"2011","unstructured":"Giudice GL, de Belvis V, Tavolato M, Galan A. Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment. Clin Ophthalmol. 2011;5:355\u201360.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"739_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3928\/23258160-20170329-08","volume":"48","author":"GJ Manayath","year":"2017","unstructured":"Manayath GJ, Karandikar SS, Narendran S, et al. Low fluence photodynamic therapy versus graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy: results from a prospective study. Ophthalmic Surg Lasers Imaging Retina. 2017;48(4):334\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"739_CR12","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.3892\/etm.2016.3886","volume":"12","author":"Y Dong","year":"2016","unstructured":"Dong Y, Wan G, Yan P, et al. Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration. Exp Ther Med. 2016;12(6):3923\u20136.","journal-title":"Exp Ther Med"},{"issue":"10","key":"739_CR13","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1167\/iovs.17-23747","volume":"59","author":"Y Gao","year":"2018","unstructured":"Gao Y, Yu T, Zhang Y, Dang G. Anti-VEGF monotherapy versus photodynamic therapy and anti-VEGF combination treatment for neovascular age-related macular degeneration: a meta-analysis. Invest Ophthalmol Vis Sci. 2018;59(10):4307\u201317.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"739_CR14","doi-asserted-by":"crossref","unstructured":"Chung YR, Lee SJ, Song JH. Changes in the choroidal thickness following intravitreal bevacizumab injection in chronic central serous chorioretinopathy. J Clin Med. 2022;11(12):3375.","DOI":"10.3390\/jcm11123375"},{"key":"739_CR15","doi-asserted-by":"crossref","unstructured":"Borrelli E, Zuccaro B, Zucchiatti I, et al. Optical coherence tomography parameters as predictors of treatment response to eplerenone in central serous chorioretinopathy. J Clin Med. 2019;8(9):1271.","DOI":"10.3390\/jcm8091271"},{"issue":"1","key":"739_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40942-022-00385-1","volume":"8","author":"CQ Felipe","year":"2022","unstructured":"Felipe CQ, Biancardi AL, Civile VT, et al. Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses. Int J Retina Vitreous. 2022;8(1):34.","journal-title":"Int J Retina Vitreous"},{"key":"739_CR17","doi-asserted-by":"crossref","unstructured":"Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003. Retina 2012;32(Suppl 1):288\u201398.","DOI":"10.1097\/IAE.0b013e31823f99a9"},{"issue":"2","key":"739_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1364\/JOSA.60.000264","volume":"60","author":"MA Mainster","year":"1970","unstructured":"Mainster MA, White TJ, Tips JH, Wilson PW. Retinal-temperature increases produced by intense light sources. J Opt Soc Am. 1970;60(2):264\u201370.","journal-title":"J Opt Soc Am"},{"issue":"5","key":"739_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3928\/1542-8877-20000901-03","volume":"31","author":"MA Mainster","year":"2000","unstructured":"Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers. 2000;31(5):359\u201373.","journal-title":"Ophthalmic Surg Lasers"},{"key":"739_CR20","unstructured":"Mainster MA, Ajlan RS. Photic retinal injuries: mechanisms, hazards and prevention. In: Sadda S, Schachat AP, Wilkinson CP, et al., editors. Ryan's retina, 7th ed. London: Elsevier, 2022; v. 2."},{"issue":"3","key":"739_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/eye.2013.13","volume":"27","author":"SH Lim","year":"2013","unstructured":"Lim SH, Chang W, Sagong M. Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy. Eye (Lond). 2013;27(3):353\u201362.","journal-title":"Eye (Lond)"},{"issue":"5","key":"739_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1089\/jop.2013.0169","volume":"30","author":"CF Liu","year":"2014","unstructured":"Liu CF, Chen LJ, Tsai SH, et al. Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy. J Ocul Pharmacol Ther. 2014;30(5):400\u20135.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"739_CR23","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1097\/IAE.0000000000003067","volume":"41","author":"S Hwang","year":"2021","unstructured":"Hwang S, Noh H, Kang SW, et al. Choroidal neovascularization secondary to photodynamic therapy for central serous chorioretinopathy: incidence, risk factors, and clinical outcomes. Retina. 2021;41(8):1762\u201370.","journal-title":"Retina"},{"issue":"8","key":"739_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/IAE.0000000000002632","volume":"40","author":"SN Markowitz","year":"2020","unstructured":"Markowitz SN, Devenyi RG, Munk MR, et al. A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration. Retina. 2020;40(8):1471\u201382.","journal-title":"Retina"},{"issue":"1","key":"739_CR25","first-page":"145","volume":"9","author":"II Geneva","year":"2016","unstructured":"Geneva II. Photobiomodulation for the treatment of retinal diseases: a review. Int J Ophthalmol. 2016;9(1):145\u201352.","journal-title":"Int J Ophthalmol"},{"key":"739_CR26","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.2147\/OPTH.S272327","volume":"15","author":"JC Muste","year":"2021","unstructured":"Muste JC, Russell MW, Singh RP. Photobiomodulation therapy for age-related macular degeneration and diabetic retinopathy: a review. Clin Ophthalmol. 2021;15:3709\u201320.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"739_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.oret.2021.10.003","volume":"6","author":"JE Kim","year":"2022","unstructured":"Kim JE, Glassman AR, Josic K, et al. A randomized trial of photobiomodulation therapy for center-involved diabetic macular edema with good visual acuity (Protocol AE). Ophthalmol Retina. 2022;6(4):298\u2013307.","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"739_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/ICU.0000000000000742","volume":"32","author":"JC Muste","year":"2021","unstructured":"Muste JC, Kalur A, Iyer A, et al. Photobiomodulation therapy in age-related macular degeneration. Curr Opin Ophthalmol. 2021;32(3):225\u201332.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"739_CR29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/S00417-017-3626-9","volume":"255","author":"A Russo","year":"2017","unstructured":"Russo A, Turano R, Morescalchi F, et al. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(6):1141\u20138. https:\/\/doi.org\/10.1007\/S00417-017-3626-9.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl","key":"739_CR30","first-page":"S85","volume":"41","author":"PA Keane","year":"2010","unstructured":"Keane PA, Aghaian E, Ouyang Y, et al. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features. Ophthalmic Surg Lasers Imaging. 2010;41(Suppl):S85\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"1","key":"739_CR31","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.jcjo.2016.08.001","volume":"52","author":"A Al-Awadi","year":"2017","unstructured":"Al-Awadi A, Mandelcorn ED, Somani S. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report. Can J Ophthalmol. 2017;52(1):e38\u201341.","journal-title":"Can J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00739-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00739-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T02:51:48Z","timestamp":1687488708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00739-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00739-4","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"5 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}